Takuhei Shoji1, Linda M Zangwill2, Tadamichi Akagi3, Luke J Saunders2, Adeleh Yarmohammadi2, Patricia Isabel C Manalastas2, Rafaella C Penteado2, Robert N Weinreb4. 1. Hamilton Glaucoma Center, Shiley Eye Institute, and Department of Ophthalmology, University of California San Diego, La Jolla, California; Department of Ophthalmology, Saitama Medical University, Iruma, Saitama, Japan. 2. Hamilton Glaucoma Center, Shiley Eye Institute, and Department of Ophthalmology, University of California San Diego, La Jolla, California. 3. Hamilton Glaucoma Center, Shiley Eye Institute, and Department of Ophthalmology, University of California San Diego, La Jolla, California; Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan. 4. Hamilton Glaucoma Center, Shiley Eye Institute, and Department of Ophthalmology, University of California San Diego, La Jolla, California. Electronic address: rweinreb@ucsd.edu.
Abstract
PURPOSE: To characterize the rate of macula vessel density loss in primary open-angle glaucoma (POAG), glaucoma-suspect, and healthy eyes. DESIGN: Longitudinal, observational cohort from the Diagnostic Innovations in Glaucoma Study. METHODS: One hundred eyes (32 POAG, 30 glaucoma-suspect, and 38 healthy) followed for at least 1 year with optical coherence tomography angiography (OCT-A) imaging on at least 2 visits were included. Vessel density was calculated in the macula superficial layer. The rate of change was compared across diagnostic groups using a multivariate linear mixed-effects model. RESULTS: Baseline macula vessel density was highest in healthy eyes, followed by glaucoma-suspect and POAG eyes (P < .01). The rate of vessel density loss was significantly different from zero in the POAG, but not in the glaucoma-suspect or healthy eyes. The mean rate of change in macula whole en face vessel density was significantly faster in glaucoma eyes (-2.23%/y) than in glaucoma-suspect (0.87%/y, P = .001) or healthy eyes (0.29%/y, P = .004). Conversely, the rate of change in ganglion cell complex (GCC) thickness was not significantly different from zero in any diagnostic group, and no significant differences in the rate of GCC change among diagnostic groups were found. CONCLUSIONS: With a mean follow-up of less than 14 months, eyes with POAG had significantly faster loss of macula vessel density than either glaucoma-suspect or healthy eyes. Serial OCT-A measurements also detected glaucomatous change in macula vessel density in eyes without evidence of change in GCC thickness.
PURPOSE: To characterize the rate of macula vessel density loss in primary open-angle glaucoma (POAG), glaucoma-suspect, and healthy eyes. DESIGN: Longitudinal, observational cohort from the Diagnostic Innovations in Glaucoma Study. METHODS: One hundred eyes (32 POAG, 30 glaucoma-suspect, and 38 healthy) followed for at least 1 year with optical coherence tomography angiography (OCT-A) imaging on at least 2 visits were included. Vessel density was calculated in the macula superficial layer. The rate of change was compared across diagnostic groups using a multivariate linear mixed-effects model. RESULTS: Baseline macula vessel density was highest in healthy eyes, followed by glaucoma-suspect and POAG eyes (P < .01). The rate of vessel density loss was significantly different from zero in the POAG, but not in the glaucoma-suspect or healthy eyes. The mean rate of change in macula whole en face vessel density was significantly faster in glaucoma eyes (-2.23%/y) than in glaucoma-suspect (0.87%/y, P = .001) or healthy eyes (0.29%/y, P = .004). Conversely, the rate of change in ganglion cell complex (GCC) thickness was not significantly different from zero in any diagnostic group, and no significant differences in the rate of GCC change among diagnostic groups were found. CONCLUSIONS: With a mean follow-up of less than 14 months, eyes with POAG had significantly faster loss of macula vessel density than either glaucoma-suspect or healthy eyes. Serial OCT-A measurements also detected glaucomatous change in macula vessel density in eyes without evidence of change in GCC thickness.
Authors: Harsha L Rao; Zia S Pradhan; Robert N Weinreb; Hemanth B Reddy; Mohammed Riyazuddin; Srilakshmi Dasari; Meena Palakurthy; Narendra K Puttaiah; Dhanaraj A S Rao; Carroll A B Webers Journal: Am J Ophthalmol Date: 2016-08-30 Impact factor: 5.258
Authors: Ute E K Wolf-Schnurrbusch; Lala Ceklic; Christian K Brinkmann; Milko E Iliev; Manuel Frey; Simon P Rothenbuehler; Volker Enzmann; Sebastian Wolf Journal: Invest Ophthalmol Vis Sci Date: 2009-02-21 Impact factor: 4.799
Authors: Felipe A Medeiros; Luciana M Alencar; Linda M Zangwill; Christopher Bowd; Gianmarco Vizzeri; Pamela A Sample; Robert N Weinreb Journal: Invest Ophthalmol Vis Sci Date: 2008-11-21 Impact factor: 4.799
Authors: Shawn Philip; Ahmad Najafi; Apichat Tantraworasin; Toco Y P Chui; Richard B Rosen; Robert Ritch Journal: Invest Ophthalmol Vis Sci Date: 2019-03-01 Impact factor: 4.799
Authors: Sasan Moghimi; Christopher Bowd; Linda M Zangwill; Rafaella C Penteado; Kyle Hasenstab; Huiyuan Hou; Elham Ghahari; Patricia Isabel C Manalastas; James Proudfoot; Robert N Weinreb Journal: Ophthalmology Date: 2019-03-08 Impact factor: 12.079
Authors: Eren Ekici; Sasan Moghimi; Christopher Bowd; Huiyuan Hou; Rafaella C Penteado; James Proudfoot; Diya Yang; Robert N Weinreb Journal: Am J Ophthalmol Date: 2020-06-17 Impact factor: 5.258
Authors: Rafaella C Penteado; Linda M Zangwill; Fábio B Daga; Luke J Saunders; Patricia I C Manalastas; Takuhei Shoji; Tadamichi Akagi; Mark Christopher; Adeleh Yarmohammadi; Sasan Moghimi; Robert N Weinreb Journal: J Glaucoma Date: 2018-06 Impact factor: 2.503
Authors: Huiyuan Hou; Sasan Moghimi; Linda M Zangwill; Takuhei Shoji; Elham Ghahari; Patricia Isabel C Manalastas; Rafaella C Penteado; Robert N Weinreb Journal: Am J Ophthalmol Date: 2018-03-24 Impact factor: 5.258